Juncture Wealth Strategies LLC purchased a new stake in shares of Moelis & Company (NYSE:MC – Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 2,800 shares of the asset manager’s stock, valued at approximately $207,000.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in MC. Reston Wealth Management LLC bought a new position in Moelis & Company in the 3rd quarter worth about $26,000. GAMMA Investing LLC raised its holdings in Moelis & Company by 115.8% in the 3rd quarter. GAMMA Investing LLC now owns 995 shares of the asset manager’s stock worth $68,000 after acquiring an additional 534 shares during the last quarter. Blue Trust Inc. lifted its position in Moelis & Company by 193.0% in the 3rd quarter. Blue Trust Inc. now owns 1,081 shares of the asset manager’s stock valued at $74,000 after acquiring an additional 712 shares in the last quarter. Whittier Trust Co. of Nevada Inc. bought a new stake in shares of Moelis & Company in the 3rd quarter worth $75,000. Finally, Benjamin F. Edwards & Company Inc. raised its stake in shares of Moelis & Company by 75.2% in the second quarter. Benjamin F. Edwards & Company Inc. now owns 1,465 shares of the asset manager’s stock worth $83,000 after purchasing an additional 629 shares during the last quarter. 91.53% of the stock is owned by hedge funds and other institutional investors.
Moelis & Company Price Performance
NYSE:MC opened at $78.12 on Friday. Moelis & Company has a one year low of $46.24 and a one year high of $81.60. The business has a fifty day moving average price of $74.98 and a 200-day moving average price of $69.86. The firm has a market capitalization of $5.85 billion, a price-to-earnings ratio of 147.40 and a beta of 1.39.
Analysts Set New Price Targets
MC has been the subject of a number of recent analyst reports. Keefe, Bruyette & Woods raised Moelis & Company from a “market perform” rating to an “outperform” rating and boosted their target price for the stock from $71.00 to $86.00 in a research report on Friday, December 20th. Wells Fargo & Company decreased their price objective on shares of Moelis & Company from $78.00 to $77.00 and set an “equal weight” rating for the company in a report on Tuesday, January 14th. UBS Group raised their target price on shares of Moelis & Company from $54.00 to $60.00 and gave the stock a “sell” rating in a report on Tuesday, October 8th. Finally, Morgan Stanley upgraded shares of Moelis & Company from an “underweight” rating to an “overweight” rating and boosted their target price for the company from $66.00 to $92.00 in a research note on Monday, December 9th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and two have given a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $70.67.
View Our Latest Research Report on MC
Moelis & Company Company Profile
Moelis & Company operates as an investment banking advisory firm. It offers advisory services in the areas of mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters, as well as strategic, capital structure, and private funds advisory.
See Also
- Five stocks we like better than Moelis & Company
- What Are Trending Stocks? Trending Stocks Explained
- Bloom Energy: Powering the Future With Decentralized Energy
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul
- 3 Warren Buffett Stocks to Buy Now
- Why Traders Are Buying the Dip on Johnson & Johnson Stock
Receive News & Ratings for Moelis & Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Moelis & Company and related companies with MarketBeat.com's FREE daily email newsletter.